Abstract-Background: The use of Negative Pressure Wound Dressing has been found to promote the wound healing process, therefore, reducing the risk of surgical site complications. The use of this technique amongst breast cancer patients, who have often encountered a distressing journey, may prove beneficial in making the post-operative process less eventful. Many of these patients have a limited time window to start adjuvant treatment. The use of a negative pressure device is recommended in both prophylactic and therapeutic scenarios. NPWT may also be used in patients who have undergone cosmetic breast surgery. We have evaluated the use of NPWT in breast surgery with an updated and systematic review of the available literature.
Introduction
T HE scope of breast surgery includes the management of benign and malignant breast disease either by mastectomy with or without reconstruction (autologous tissue as well as implant-based) or breast conservative surgery. Furthermore, it also encompasses aesthetic surgery such as breast augmentation or reduction. Complications associated with the post-operative wound-healing process remain one of the most common challenges and are potentially associated with delaying adjuvant therapy and diminishing the aesthetic result.
The benefits of using the Negative Pressure Wound Dressing in Breast surgery have been well documented.
Breast cancer is considered the most frequently detected female malignancy worldwide and the dominant cause of cancer-related mortality amongst women. 1 Although breast surgery is typically associated with a low risk of surgical site infection (SSI), the use of the Negative Pressure Wound Dressing further results in a favorable outcome.
We have studied available data that discuss the effectiveness of negative pressure wound therapy (NPWT) systems in the management of post-surgical wounds involving the breast.
Methods
The PRISMA principles have been followed during this review preparation. The PubMed, Science Direct, Wiley Online databases, and Scopus databases have been searched systematically. All the papers that revealed relevant data were considered eligible for inclusion in the review.
Inclusion criteria
We have looked at studies involving patients that underwent surgical breast procedures. The intervention under exploration was the use of NPWT in postoperative wounds. The comparator treatment was conventional dressings including dry wound dressing, alginate dressings or salinesoaked gauze dressings. Original papers such as randomized controlled trials (RCTs), retrospective studies, prospective studies, and case series have been included and the full text of the paper was explored. Papers that do not refer to the use of NPWT in breast surgery were excluded. The primary outcome was complete wound closure. No minimum patient sample size per trial was required and no restriction was placed for study dates or periods. After selection, seven original research papers met the inclusion criteria and were finally included in this review,(one randomized trial, three cohort retrospective studies, two prospective studies, and one Medigent.org c b DOI: 10.18487/npwtj.v6i4.53 case series). The studies involved 492 female patients treated with NPWT versus 584 patients treated with conventional dressing methods.
Results

A. Mechanism of action
The use of Negative Pressure Wound Dressing promotes wound healing by triggering several healing pathways i.e. angiogenesis which improves tissue oxygenation and aids migrating the inflammatory cells to the healing site. It also aids the diversion of the wound exudate away from the wound and promotes patient independence and improves quality of life. [2] [3] [4] 
B. Device types and indications
The current devices that provide NPWT are vacuumassisted closure (VAC) system and PICO TM dressing. The PICO TM dressing is a canister free; single-use topical NPWT system that maintains -80 mmHg pressure (Fig. 2) . The NPWT systems are used to manage complex wounds such as those which are infected, diabetic foot ulcers, post-traumatic wounds, burns, and necrotizing fasciitis. 5 NPWT concept is continually evolving. In addition to the use of conventional NPWT it may also be used to manage post-surgical wound complications or as a prophylactic measure to reduce the infection risk. 6 Negative Pressure Wound Therapy with the installation system (NPWTi) has also been developed. It incorporates the traditional NPWT and a local irrigation system within the wound cavity. NPWTi significantly reduces the growth of biofilm that colonize the wound cavity. Such formation of biofilm is considered to be one of the main factors impairing the wound healing process. 7 Stoeckel et al. retrospectively analyzed the data of 18 patients who had post-operative breast wound complications treated with NPWT. 15 of the patients underwent surgery for breast cancer, two had reduction mammoplasty, and one was treated for a recurrent primary breast abscess. 12 of the 15 cancer patients underwent mastectomy had subsequent breast reconstruction procedures. Seven wounds were related to implant or tissue expander placement. Four patients had complicated transverse rectus abdominus myocutaneous (TRAM) flap wounds, and one had a latissimus dorsi flap wound. 15 of 18 patients were treated effectively using NPWT. Two patients required muscle flap coverage. The hospital stay ranged from 3 to 54 days with a mean of 12.1 days. NPWT dressing has been used to promote wound healing after skin grafting, or as a mean to prepare the wound for surgical closure. Seven of the wounds healed by secondary intention, six were successfully treated with subsequent skin grafting, and two were treated with delayed primary closure. Two wounds were both complicated by tissue ischemia and infection requiring operative debridement (Tab. I). The authors concluded that vacuum-assisted closure therapy promotes faster healing and stimulates the formation of healthy granulation tissue. 8 
C. NPWT in oncoplastic breast surgery boosts incision closure
Holt and Murphy from South Manchester University Hospital conducted a study to assess if the application of negative pressure wound therapy dressings (PICO TM ) on closed incisions in patients undergoing therapeutic resection promotes superior wound healing. 24 consecutive patients (over 20 months) were included in the study. They either underwent a therapeutic mammoplasty or skin-sparing mastectomy and immediate reconstruction with inferior dermal flap and implant placement. All patients had a simultaneous symmetric breast reduction at the same sitting. The therapeutic procedure side was supplied with PICO TM dressings while the opposite breast reduction was dressed with conventional dressings. The overall rate of wound dehiscence was 4.2% (n = 1) on the therapeutic procedure side compared with 16.7% (n = 4) on the contralateral breast reduction side. The mean time to complete healing was 10.7 days in the therapeutic side treated with PICO TM compared with 16.1 days on the contralateral side. One mastectomy patient had delayed wound healing at the T-junction on both sides (Tab. I). The authors concluded that this evidence further supports the use of NPWT in oncoplastic breast procedures, as it reduces the rates of wound dehiscence, boosts healing, and allows commencement of adjuvant therapy. 9 Ferrando et al. conducted a prospective study that included 37 cases. ciNPT was used in 17 cases (46%), whereas the remaining 20 (54%) had conventional post-operative wound dressing. The difference in complication rate between the 2 groups was significant, the ciNPT sample showed complication rates of only 1/25 (4%), as compared to 45% (10 out of 22) in the standard care group (Tab. I). The study outcome supports the use of ciNPT in oncological breast surgery. Furthermore, the dressing is well-tolerated, adaptable, and has shown to improve scar outcomes especially in patients presenting with high-risk factors. 10 Gabriel et al. investigated closed incision Negative Pressure Therapy (ciNPT) with a customizable dressing on 13 patients (25 breasts) who received immediate postmastectomy reconstruction as part of 2-stage expander/implant breast reconstruction. Nipple-sparing mastectomy was performed on 14 breasts, reduction-pattern mastectomy on 6 breasts, and skin-sparing mastectomy on 5 breasts. All post-mastectomy incisions were managed with ciNPT. The single-use therapy unit provided continuous negative pressure (-125 mmHg) with a replaceable 45 ml exudate canister. The wound dressing and ciNPT unit were designed for placement for up to 7 days. Surgical drains were routed under the skin beyond the ciNPT dressing and they functioned independently of ciNPT . The majority of patients (56.0%) were treated with nipplesparing mastectomy. Overall mean ciNPT duration ranged from 3 to 5 days. The mean drain placement was 8.2 days. After three months follow-up, 96% (24/25 breasts) achieved complete healing. Superficial dehiscence occurred in 12% (3/25 breasts), and flap necrosis occurred in 4% (1/25 breasts) in the breast reduction-pattern group. One patient from the nipple-sparing mastectomy group developed a delayed hematoma postoperatively. No superficial wound dehiscence required surgical intervention. One obese, diabetic patient developed a flap necrosis which required surgical revision. All other breasts healed and remained closed at 3-month follow-up (Tab. I). The paper concluded that ciNPT could be a viable option for wounds after immediate post-mastectomy reconstruction. 11 In a cohort of 206 patients (228 breasts), Kim et al. examined the usefulness of the ciNPT to reduce mastectomy flap necrosis in immediate expander-based breast reconstruction. The incisional-NPWT group (45 breasts) had a lower overall complication rate in comparison with a conventional dressing group (11.1% vs. 27.9%, p = 0.019). In detail, the overall mastectomy flap necrosis rate was 8.9 % (versus 23.5 %; p = 0.030), and major mastectomy flap necrosis rate was 2.2 % (versus 13.7 %; p = 0.031 compared with the conventional dressing group, Tab. I). The paper concluded that the use of NPWT is an effective method in reducing mastectomy flap necrosis in expander-based breast reconstruction. 12 Gabriel et al. conducted a retrospective study comparing postoperative outcomes in patients who were treated with ciNPT versus standard of care (SOC) after breast reconstruction following mastectomy procedures. The authors investigated the medical records of 356 patients (ciNPT = 177, SOC = 179) with 665 closed breast incisions (ciNPT = 331, SOC = 334). Overall complication rate was 8.5% (28/331) in ciNPT group compared with 15.9% (53/334) in SOC group (p = 0.0092). Compared with the SOC group, the ciNPT group had significantly lower infection rates (7/331 (2.1%) versus 15/334 (4.5%), respectively; p = 0.0225). Time to complete drain removal per breast for ciNPT versus SOC groups was 9.9 versus 13.1 days (p < 0.0001), respectively. Patients who received ciNPT over closed incisions following mastectomy and breast reconstruction experienced a shorter time to surgical drain removal and significantly lower rates of infection, dehiscence, necrosis, and seromas, compared with the SOC group. 13 D. NPWT in breast surgery transplants Angspatt et al. in 2017 evaluated the efficacy of NPWT in preventing donor site seroma formation after the harvest of a latissimus dorsi muscle flap for breast reconstruction. It was a prospective matched-pair study, 40 patients were included. 20 patients had NPWT dressing at the donor site, and conventional wound dressing was used in the control group (n = 20). In the NPWT group, seroma incidence after the drain removal was significantly lower than in the control group (15% vs. 70%; odds ratio = 0.07, relative risk, 0.24). Both the mean percutaneous aspirated volume (p = 0.004) and the frequency of percutaneous aspirations (p = 0.001) were also significantly lower in the NPWT group (Tab. I). The paper concluded that the use of NPWT reduces the seroma incidence after drain removal from the latissimus dorsi flap harvesting site. 14 
E. ciNPT after reduction mammoplasty decreases wound dehiscence risk
Galiano et al. presented a multinational, prospective, randomized, open trial to evaluate the efficacy of PICO TM (canister free; single-use NPWT system) on the prevention of post-surgical incision healing complications in 200 patients undergoing bilateral reduction mammoplasty (Tab. I). One patient arm was treated with PICO TM on one breast and Steristrips on the contralateral side. This group was assessed for local wound complications three weeks after the operation. Secondary objectives were to assess post-surgical complications (such as skin necrosis, hematoma, wound dehiscence and seromas), scar quality and the ease of application of PICO TM versus standard wound care. The outcome revealed a trend towards fewer complications and adverse events in the PICO TM group compared to conventional wound care. Results also found a 38% decrease in wound dehiscence, which was statistically significant. 15 
F. Complex cases
NPWT can also be used to manage complex postoperative complications relating to breast implant placement such as 
G. Surgical Site Infection and NPWT
It has been reported that NPWT, when applied prophylactically to a closed surgical wound, results in a decrease in the incidence of wound complications such as infection or collection of fluid. 15 Strugala et al., in 2017, conducted a meta-analysis to determine the impact of prophylactic use of NPWT on SSI, wound dehiscence and length of hospital stay. The outcome revealed a significant reduction of SSI from 12.5% to 5.2% with NPWT use. Wound dehiscence rate was reduced from 17.4% to 12.8% with NPWT, and the mean reduction in hospital length of stay (in patients treated with NPWT) was also significant (-0.47 days). Such observations also encourage the use of NPWT in a wide range of abdominal, orthopedic and colorectal procedures. 18 Post-operative wound-related complications following breast surgery varies from 7 to 31% in the literature. 19, 20 Consequences include a prolonged hospital stay, delay in adjuvant treatment delivery, poor cosmesis, the need for further surgery and increased management costs. Furthermore, the use of negative pressure wound dressing and its associated benefits in reducing complications plays a part in easing a patient's psychological stress in the post-operative period.
Conclusion
One in eight women is affected by breast cancer during their lifetime and surgery is an essential element in the management pathway. 21 As the majority of breast cancer patients will require adjuvant treatment after surgery, swift recovery is essential in preventing delays. Such delays ultimately affect outcome and survival. Furthermore, NPWT may play a role in improving the cosmetic outcome by reducing the tension in the surgical wound, obliteration of the dead space and minimizing tissue injury by protecting the wound from contamination and infection. 22 Randomized controlled clinical trials that are currently under progress will show if the NPWT is able to provide women underging immediate breast reconstruction, better outcomes due to a faster healing process and superior aesthetic results when compared to the conventional post-operative wound dressings. 23 The current evidence supports the notion that NPWT systems are beneficial in enhancing the healing of complicated breast wounds. However, larger studies exploring the effectiveness of this technique are required.
